Hurel receives USD9.2m Series A funding from Spring Mountain Capital
Spring Mountain Capital has organised and closed a USD9.2m Series A private equity financing facility for the Hurel Corporation, a provider of advanced artificial tissue constructs and microfluidic cell-based assay platforms. Funds from the financing will support the commercial launch of Hurel’s current products, the continued research and development
